RESEARCH - No safety signal with rituximab + TNF inhibitor + MTX

[Guest guest]

Rituximab Combined With a TNF Inhibitor and Methotrexate Shows No

Safety Signal in Rheumatoid Arthritis Treatment, Study Finds

ScienceDaily (Mar. 8, 2011) — A recent trial of rituximab in

combination with a tumor necrosis factor (TNF) inhibitor and

methotrexate (MTX) in patients with active rheumatoid arthritis (RA)

found the safety profile to be consistent with other RA trials with

TNF inhibitors. While the trial reported no new safety risks, clear

evidence of an efficacy advantage in RA patients receiving the

combination therapy was not observed in this study sample.

*************************************************

Read the full article here:

http://www.sciencedaily.com/releases/2011/03/110308084745.htm

Not an MD